Australia Immuno Chemistry Market Outlook to 2024

Published : Nov-2017

No. of Pages : 116

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Immuno Chemistry Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 8
3 Immuno Chemistry Market, Australia 12
3.1 Immuno Chemistry Market, Australia, Revenue ($m), 2010-2017 12
3.2 Immuno Chemistry Market, Australia, Revenue ($m), 2017-2024 14
3.2.1 Complement Deficiency Tests Market, Australia, Revenue ($m), by Segment, 2010-2017 16
3.2.2 Diabetes Assays Market, Australia, Revenue ($m), by Segment, 2010-2017 18
3.2.3 Disease Specific Immunochemistry Market, Australia, Revenue ($m), by Segment, 2010-2017 20
3.2.4 Endocrinology Tests Market, Australia, Revenue ($m), by Segment, 2010-2017 22
3.2.5 IgE Allergy Blood Tests Market, Australia, Revenue ($m), by Segment, 2010-2017 24
3.2.6 Immunochemistry Analyzers Market, Australia, Revenue ($m), by Segment, 2010-2017 26
3.2.7 Immunochemistry Rapid Tests & POC Market, Australia, Revenue ($m), by Segment, 2010-2017 28
3.2.8 Vitamins Tests Market, Australia, Revenue ($m), by Segment, 2010-2017 30
3.2.9 Complement Deficiency Tests Market, Australia, Revenue ($m), by Segment, 2017-2024 32
3.2.10 Diabetes Assays Market, Australia, Revenue ($m), by Segment, 2017-2024 34
3.2.11 Disease Specific Immunochemistry Market, Australia, Revenue ($m), by Segment, 2017-2024 36
3.2.12 Endocrinology Tests Market, Australia, Revenue ($m), by Segment, 2017-2024 38
3.2.13 IgE Allergy Blood Tests Market, Australia, Revenue ($m), by Segment, 2017-2024 40
3.2.14 Immunochemistry Analyzers Market, Australia, Revenue ($m), by Segment, 2017-2024 42
3.2.15 Immunochemistry Rapid Tests & POC Market, Australia, Revenue ($m), by Segment, 2017-2024 44
3.2.16 Vitamins Tests Market, Australia, Revenue ($m), by Segment, 2017-2024 46
3.3 Immuno Chemistry Market, Australia, Volume (Units), 2010-2017 48
3.4 Immuno Chemistry Market, Australia, Volume (Units), 2017-2024 50
3.4.1 Complement Deficiency Tests Market, Australia, Volume (Units), by Segment, 2010-2017 52
3.4.2 Diabetes Assays Market, Australia, Volume (Units), by Segment, 2010-2017 54
3.4.3 Disease Specific Immunochemistry Market, Australia, Volume (Units), by Segment, 2010-2017 56
3.4.4 Endocrinology Tests Market, Australia, Volume (Units), by Segment, 2010-2017 58
3.4.5 IgE Allergy Blood Tests Market, Australia, Volume (Units), by Segment, 2010-2017 60
3.4.6 Immunochemistry Analyzers Market, Australia, Volume (Units), by Segment, 2010-2017 62
3.4.7 Immunochemistry Rapid Tests & POC Market, Australia, Volume (Units), by Segment, 2010-2017 64
3.4.8 Vitamins Tests Market, Australia, Volume (Units), by Segment, 2010-2017 66
3.4.9 Complement Deficiency Tests Market, Australia, Volume (Units), by Segment, 2017-2024 68
3.4.10 Diabetes Assays Market, Australia, Volume (Units), by Segment, 2017-2024 70
3.4.11 Disease Specific Immunochemistry Market, Australia, Volume (Units), by Segment, 2017-2024 72
3.4.12 Endocrinology Tests Market, Australia, Volume (Units), by Segment, 2017-2024 74
3.4.13 IgE Allergy Blood Tests Market, Australia, Volume (Units), by Segment, 2017-2024 76
3.4.14 Immunochemistry Analyzers Market, Australia, Volume (Units), by Segment, 2017-2024 78
3.4.15 Immunochemistry Rapid Tests & POC Market, Australia, Volume (Units), by Segment, 2017-2024 80
3.4.16 Vitamins Tests Market, Australia, Volume (Units), by Segment, 2017-2024 82
3.5 Immuno Chemistry Market, Australia, Average Price ($), 2010-2024 84
3.6 Immuno Chemistry Market, Australia, Distribution Share by Revenue ($m), 2017 88
3.7 Immuno Chemistry Market, Australia, Company Share by Revenue ($m), 2017 89
4 Overview of Key Companies in Australia, Immuno Chemistry Market 91
4.1 F. Hoffmann-La Roche Ltd 91
4.1.1 Company Overview 91
4.2 Siemens Healthcare GmbH 91
4.2.1 Company Overview 91
4.3 Beckman Coulter Inc 91
4.3.1 Company Overview 91
4.4 Thermo Fisher Scientific Inc 92
4.4.1 Company Overview 92
4.5 Abbott Laboratories 92
4.5.1 Company Overview 92
4.6 Bio-Rad Laboratories Inc 92
4.6.1 Company Overview 92
4.7 bioMerieux SA 92
4.7.1 Company Overview 92
5 Immuno Chemistry Market Pipeline Products 93
6 Financial Deals Landscape 96
6.1 Debt Offerings 96
6.1.1 CSL Raises USD250 Million in Private Placement of 3.17% Debt Securities Due 2027 96
6.1.2 CSL Raises USD200 Million in Private Placement of 3.32% Debt Securities Due 2029 97
6.1.3 CSL Raises USD150 Million in Private Placement of 3.47% Debt Securities Due 2032 98
6.1.4 CSL Raises USD100 Million in Private Placement of 3.77% Debt Securities Due 2037 99
6.2 Equity Offerings 100
6.2.1 Biotron to Raise USD1.2 Million in Rights Offering of Shares 100
7 Recent Developments 102
7.1 Financial Announcements 102
7.1.1 Aug 16, 2017: CSL announces Full Year Result 2017 102
7.1.2 Feb 15, 2017: CSL Announces Half Year Result 2017 103
7.1.3 Jan 19, 2017: CSL reports FY2017 profit upgrade 104
7.2 Legal And Regulatory 104
7.2.1 Jul 19, 2017: TBG Diagnostics Received ASHI accreditation for Xiamen facility 104
7.3 Other Significant Developments 105
7.3.1 Sep 11, 2017: Pharming Announces Conclusion of FDA End of Phase 2 Interactions on RUCONEST for Prophylaxis of HAE 105
7.3.2 Aug 02, 2017: New Australian studies reveal that both infants and GP office patients are exposed to considerably more antibiotics than needed 106
7.3.3 Dec 09, 2016: Adherium's Smartinhaler Technology Chosen for Major Asthma Initiative 106
7.4 Product News 108
7.4.1 Aug 31, 2017: New screening test could help identify pregnancy complications 108
7.4.2 Jun 09, 2017: Gold Standard Technique For Cancer Research Revealed By Global Study 108
8 Appendix 110
8.1 Research Methodology 111
8.1.1 Coverage 111
8.1.2 Secondary Research 111
8.1.3 Primary Research 112
8.1.4 Market Modeling and Forecasting 113
8.1.5 Company Share Analysis 114
8.1.6 Distribution Share Analysis 115
8.1.7 Benchmarking 115
8.2 GlobalData Consulting 115
8.3 Contact Us 116
8.4 Disclaimer 116

1.1 List of Tables
Table 1: Immuno Chemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 13
Table 2: Immuno Chemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 15
Table 3: Complement Deficiency Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 17
Table 4: Diabetes Assays Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 19
Table 5: Disease Specific Immunochemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 21
Table 6: Endocrinology Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 23
Table 7: IgE Allergy Blood Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 25
Table 8: Immunochemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 27
Table 9: Immunochemistry Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 29
Table 10: Vitamins Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 31
Table 11: Complement Deficiency Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 33
Table 12: Diabetes Assays Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 35
Table 13: Disease Specific Immunochemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 37
Table 14: Endocrinology Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 39
Table 15: IgE Allergy Blood Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 41
Table 16: Immunochemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 43
Table 17: Immunochemistry Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 45
Table 18: Vitamins Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 47
Table 19: Immuno Chemistry Market, Australia, Volume (Units), Historic, 2010-2017 49
Table 20: Immuno Chemistry Market, Australia, Volume (Units), Forecast, 2017-2024 51
Table 21: Complement Deficiency Tests Market, Australia, Volume (Units), Historic, 2010-2017 53
Table 22: Diabetes Assays Market, Australia, Volume (Units), Historic, 2010-2017 55
Table 23: Disease Specific Immunochemistry Market, Australia, Volume (Units), Historic, 2010-2017 57
Table 24: Endocrinology Tests Market, Australia, Volume (Units), Historic, 2010-2017 59
Table 25: IgE Allergy Blood Tests Market, Australia, Volume (Units), Historic, 2010-2017 61
Table 26: Immunochemistry Analyzers Market, Australia, Volume (Units), Historic, 2010-2017 63
Table 27: Immunochemistry Rapid Tests & POC Market, Australia, Volume (Units), Historic, 2010-2017 65
Table 28: Vitamins Tests Market, Australia, Volume (Units), Historic, 2010-2017 67
Table 29: Complement Deficiency Tests Market, Australia, Volume (Units), Forecast, 2017-2024 69
Table 30: Diabetes Assays Market, Australia, Volume (Units), Forecast, 2017-2024 71
Table 31: Disease Specific Immunochemistry Market, Australia, Volume (Units), Forecast, 2017-2024 73
Table 32: Endocrinology Tests Market, Australia, Volume (Units), Forecast, 2017-2024 75
Table 33: IgE Allergy Blood Tests Market, Australia, Volume (Units), Forecast, 2017-2024 77
Table 34: Immunochemistry Analyzers Market, Australia, Volume (Units), Forecast, 2017-2024 79
Table 35: Immunochemistry Rapid Tests & POC Market, Australia, Volume (Units), Forecast, 2017-2024 81
Table 36: Vitamins Tests Market, Australia, Volume (Units), Forecast, 2017-2024 83
Table 37: Immuno Chemistry Market, Australia, Average Price ($) Historic, 2010-2017 84
Table 38: Immuno Chemistry Market, Australia, Average Price ($), Forecast, 2017-2024 86
Table 39: Immuno Chemistry Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2017 88
Table 40: Immuno Chemistry Market, Australia, Company Share by Revenue ($m), USD Constant, 2017 90
Table 41: Immuno Chemistry Market Pipeline Products 93
Table 42: CSL Raises USD250 Million in Private Placement of 3.17% Debt Securities Due 2027 96
Table 43: CSL Raises USD200 Million in Private Placement of 3.32% Debt Securities Due 2029 97
Table 44: CSL Raises USD150 Million in Private Placement of 3.47% Debt Securities Due 2032 98
Table 45: CSL Raises USD100 Million in Private Placement of 3.77% Debt Securities Due 2037 99
Table 46: Biotron to Raise USD1.2 Million in Rights Offering of Shares 100
Table 47: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 113

1.2 List of Figures
Figure 1: Immuno Chemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 12
Figure 2: Immuno Chemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 14
Figure 3: Complement Deficiency Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 16
Figure 4: Diabetes Assays Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 18
Figure 5: Disease Specific Immunochemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 20
Figure 6: Endocrinology Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 22
Figure 7: IgE Allergy Blood Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 24
Figure 8: Immunochemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 26
Figure 9: Immunochemistry Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 28
Figure 10: Vitamins Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 30
Figure 11: Complement Deficiency Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 32
Figure 12: Diabetes Assays Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 34
Figure 13: Disease Specific Immunochemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 36
Figure 14: Endocrinology Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 38
Figure 15: IgE Allergy Blood Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 40
Figure 16: Immunochemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 42
Figure 17: Immunochemistry Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 44
Figure 18: Vitamins Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 46
Figure 19: Immuno Chemistry Market, Australia, Volume (Units), Historic, 2010-2017 48
Figure 20: Immuno Chemistry Market, Australia, Volume (Units), Forecast, 2017-2024 50
Figure 21: Complement Deficiency Tests Market, Australia, Volume (Units), Historic, 2010-2017 52
Figure 22: Diabetes Assays Market, Australia, Volume (Units), Historic, 2010-2017 54
Figure 23: Disease Specific Immunochemistry Market, Australia, Volume (Units), Historic, 2010-2017 56
Figure 24: Endocrinology Tests Market, Australia, Volume (Units), Historic, 2010-2017 58
Figure 25: IgE Allergy Blood Tests Market, Australia, Volume (Units), Historic, 2010-2017 60
Figure 26: Immunochemistry Analyzers Market, Australia, Volume (Units), Historic, 2010-2017 62
Figure 27: Immunochemistry Rapid Tests & POC Market, Australia, Volume (Units), Historic, 2010-2017 64
Figure 28: Vitamins Tests Market, Australia, Volume (Units), Historic, 2010-2017 66
Figure 29: Complement Deficiency Tests Market, Australia, Volume (Units), Forecast, 2017-2024 68
Figure 30: Diabetes Assays Market, Australia, Volume (Units), Forecast, 2017-2024 70
Figure 31: Disease Specific Immunochemistry Market, Australia, Volume (Units), Forecast, 2017-2024 72
Figure 32: Endocrinology Tests Market, Australia, Volume (Units), Forecast, 2017-2024 74
Figure 33: IgE Allergy Blood Tests Market, Australia, Volume (Units), Forecast, 2017-2024 76
Figure 34: Immunochemistry Analyzers Market, Australia, Volume (Units), Forecast, 2017-2024 78
Figure 35: Immunochemistry Rapid Tests & POC Market, Australia, Volume (Units), Forecast, 2017-2024 80
Figure 36: Vitamins Tests Market, Australia, Volume (Units), Forecast, 2017-2024 82
Figure 37: Immuno Chemistry Market, Australia, Company Share (%) 2017 89

Filed in: In Vitro Diagnostic, Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......	$4950
Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact) Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......	$7500
Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......	$7500
Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028 Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......	$10995
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......	$7500
Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......	$7500
EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......	$7500
Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......	$7500
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model "Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......	$7500
Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Prenatal Screening is now routinely used in developed countries for early detection of fetal abnormalities. Various biochemical analytes are measured during the first or second trimester including free-beta human chorionic gonadotropin (hCG), total hCG, pregnancy associated plasma protein-A (PAPP-A), Alpha-fetoprotein (AFP), unconjugated estriol (uE3), and Inhibin A. These markers are used to screen for Down syndrome (Trisomy 21) as well as Edwards syndrome (Trisomy 18) and ectopic pregnancy. Additionally, maternal s......	$7500

Australia Immuno Chemistry Market Outlook to 2024

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026

Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model